Metagenomi, Inc Common Stock

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$8,513
$4,127
$9,614
$11,514
Gross Profit
8,513
4,127
9,614
11,514
EBITDA
-19,652
-26,462
-19,162
-21,019
EBIT
-20,987
-27,820
-20,623
-22,383
Net Income
-19,908
-25,039
-23,398
-18,773
Net Change In Cash
8,513
4,127
9,614
11,514
Free Cash Flow
-21,378
-23,130
-26,610
-27,838
Cash
26,850
29,195
27,386
25,117
Basic Shares
37,156
37,019
37,092
36,766

Annual Financials

Values in thousands 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Revenue
$52,295
$44,756
$17,200
$243
Gross Profit
52,295
40,549
15,467
-144
EBITDA
-83,494
-74,285
-39,193
-20,753
EBIT
-88,901
-78,492
-40,926
-21,140
Net Income
-78,058
-68,255
-43,593
-21,442
Net Change In Cash
52,295
44,756
17,200
243
Free Cash Flow
-112,187
-101,223
15,747
21,354
Cash
27,386
140,603
184,441
39,296
Basic Shares
37,418
37,472
37,472
5,929

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$0.54
2025-03-31
-$0.68
2024-12-31
-$0.37